ArticleBlood2023

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.

Andrew J Dunbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.